These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 402162)

  • 61. Enhanced susceptibility of glutaraldehyde-treated tumor cells to antibody-dependent macrophage-mediated cytolysis.
    Iwata-Dohi N; Esumi-Kurisu M; Ikenami M; Sadatsune K; Mizuno D; Yamazaki M
    Cancer Res; 1982 Aug; 42(8):3196-200. PubMed ID: 6807539
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cross-linking and coupling of rabbit muscle aldolase and glyceraldehyde-3-phosphate dehydrogenase by glutaraldehyde.
    Hajdu J; Solti M; Friedrich P
    Acta Biochim Biophys Acad Sci Hung; 1975; 10(1-2):7-16. PubMed ID: 807079
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effect of preservation with metaperiodate and glutaraldehyde on the immunogenic properties of vessels].
    Barbarash LS; Sergeev VN
    Biull Eksp Biol Med; 1978 Nov; 86(11):554-6. PubMed ID: 214184
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Complement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysis.
    Shah TA; Mauriello CT; Hair PS; Sharp JA; Kumar PS; Lattanzio FA; Werner AL; Whitley PH; Maes LA; Cunnion KM; Krishna NK
    Transfusion; 2014 Nov; 54(11):2892-900. PubMed ID: 24806146
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sequential substages of natural killer cell-derived cytolytic factor (NKCF)-mediated cytolysis as defined by glutaraldehyde modulation of the target cell.
    Deem RL; Targan SR
    J Immunol; 1984 Oct; 133(4):1836-40. PubMed ID: 6432901
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enhancement of the biological activities of soybean agglutinin by cross-linking with glutaraldehyde.
    Lotan R; Lis H; Rosenwasser A; Novogrodsky A; Sharon N
    Biochem Biophys Res Commun; 1973 Dec; 55(4):1347-55. PubMed ID: 4203906
    [No Abstract]   [Full Text] [Related]  

  • 67. Stimulation in the primary and secondary mixed lymphocyte reaction by mitogen-stimulated, glutaraldehyde-fixed mouse spleen cells.
    Lightbody J; Kong YM
    Transplant Proc; 1977 Mar; 9(1):679-81. PubMed ID: 141137
    [No Abstract]   [Full Text] [Related]  

  • 68. Mitogen-stimulated glutaraldehyde-fixed spleen cells: ability to stimulate in the mixed lymphocyte reaction and generate effector cells in cell-mediated lympholysis.
    Lightbody JJ; Kong YM
    J Immunol; 1976 Oct; 117(4):1336-9. PubMed ID: 135809
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Kinetics of erythrocyte swelling and membrane hole formation in hypotonic media.
    Pribush A; Meyerstein D; Meyerstein N
    Biochim Biophys Acta; 2002 Feb; 1558(2):119-32. PubMed ID: 11779562
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Purification of the LaSota strain of Newcastle disease virus with the use of glutarate-treated erythrocytes].
    Trybała E
    Med Dosw Mikrobiol; 1983; 35(1):61-4. PubMed ID: 6415355
    [No Abstract]   [Full Text] [Related]  

  • 71. [Rapid agglutination of glutaraledhyde-treated erythrocytes by some gram negative bacteria (author's transl)].
    Hausner O
    Cesk Epidemiol Mikrobiol Imunol; 1982 May; 31(3):173-7. PubMed ID: 6212137
    [No Abstract]   [Full Text] [Related]  

  • 72. Lysosomal enzyme activities of human fetal organs during development.
    Shin-Buehring YS; Dallinger M; Osang M; Rahm P; Schaub J
    Biol Neonate; 1980; 38(5-6):300-8. PubMed ID: 6251927
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of hydroformylation treatment on the storage time and blood group antigen expressions of reagent red blood cells.
    Yu Y; Sun X; Guan X; Zhang X; Ma C; Chen L; Wang D
    Transfus Apher Sci; 2014 Jun; 50(3):462-6. PubMed ID: 24661843
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Factors that influence the uptake and turnover of glucocerebrosidase and alpha-galactosidase in mammalian liver.
    Pentchev PG; Kusiak JW; Barranger JA; Furbish FS; Rapoport SI; Massey JM; Brady RO
    Adv Exp Med Biol; 1978; 101():745-52. PubMed ID: 208371
    [No Abstract]   [Full Text] [Related]  

  • 75. Clearance of heterologous, homologous and damaged homologous erythrocytes by the isolated perfused rat liver.
    Vömel T; Hager K; Platt D
    Vet Immunol Immunopathol; 1988 Jun; 18(4):361-8. PubMed ID: 3137721
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antimicrobial and other properties of a new stabilized alkaline glutaraldehyde disinfectant/sterilizer.
    Miner NA; McDowell JW; Willcockson GW; Bruckner NI; Stark RL; Whitmore EJ
    Am J Hosp Pharm; 1977 Apr; 34(4):376-82. PubMed ID: 16488
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Method for the stabilization of E-rosettes with glutaraldehyde].
    Fuchs R; Becker U; Eckstein E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(3):370-5. PubMed ID: 80364
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differences in coagulability of three glutaraldehyde solutions in the glutaraldehyde test on bovine whole blood.
    Mahin L; Chadli M; Marzou A; Maach L; Ychou M
    Zentralbl Veterinarmed A; 1985 Feb; 32(2):151-4. PubMed ID: 3922167
    [No Abstract]   [Full Text] [Related]  

  • 79. Pharmacokinetics and biodistribution of amikacin encapsulated in carrier erythrocytes.
    Gutiérrez Millán C; Zarzuelo Castañeda A; González López F; Sayalero Marinero ML; Lanao JM
    J Antimicrob Chemother; 2008 Feb; 61(2):375-81. PubMed ID: 18096557
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Procedure for the manufacture of vaccines by means of glutaraldehyde].
    Relyveld EH; Girard O; Désormeau-Bedot JP
    Ann Immunol Hung; 1973; 17():21-31. PubMed ID: 4218935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.